225 related articles for article (PubMed ID: 3139596)
1. A synthetic adjuvant effective in inducing antitumor immunity.
Kataoka T; Tokunaga T
Jpn J Cancer Res; 1988 Jul; 79(7):817-20. PubMed ID: 3139596
[TBL] [Abstract][Full Text] [Related]
2. Effect of a synthetic adjuvant for inducing anti-tumour immunity.
Kataoka T; Kinomoto M; Takegawa M; Tokunaga T
Vaccine; 1991 May; 9(5):300-2. PubMed ID: 1872013
[TBL] [Abstract][Full Text] [Related]
3. B30-MDP, a synthetic muramyl dipeptide derivative for tumour vaccination to enhance antitumour immunity and antimetastatic effect in mice.
Yoo YC; Saiki I; Sato K; Azuma I
Vaccine; 1992; 10(11):792-7. PubMed ID: 1441733
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
Tsujimoto M; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
[TBL] [Abstract][Full Text] [Related]
5. Persistent enhancement of cell-mediated and antibody immune responses after administration of muramyl dipeptide derivatives with antigen in metabolizable oil.
Carelli C; Audibert F; Chedid L
Infect Immun; 1981 Jul; 33(1):312-4. PubMed ID: 7263069
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
[TBL] [Abstract][Full Text] [Related]
7. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
8. Histological study of local skin injected with adjuvant-active and -inactive muramyl dipeptide (MDP) (histological change in MDP injected skin.
Okuyama H; Kobayashi S; Azuma I
Asian Pac J Allergy Immunol; 1983 Dec; 1(2):89-96. PubMed ID: 6681013
[No Abstract] [Full Text] [Related]
9. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y
Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634
[TBL] [Abstract][Full Text] [Related]
10. Effect of quinonyl-N-acetyl muramyl dipeptide on immune responses in tumor-bearing mice.
Saiki I; Tanio Y; Yamamoto KI; Yamamura Y; Azuma I
Infect Immun; 1983 Jan; 39(1):137-41. PubMed ID: 6822411
[TBL] [Abstract][Full Text] [Related]
11. The comparative selectivity of adjuvants for humoral and cell-mediated immunity. II. Effect on delayed-type hypersensitivity in the mouse and guinea pig, and cell-mediated immunity to tumour antigens in the mouse of Freund's incomplete and complete adjuvants, alhydrogel, Corynebacterium parvum, Bordetella pertussis, muramyl dipeptide and saponin.
Bomford R
Clin Exp Immunol; 1980 Feb; 39(2):435-41. PubMed ID: 6248283
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of humoral immune responses against viral vaccines by a non-pyrogenic 6-O-acylmuramyldipeptide and synthetic low toxicity analogues of lipid A.
Tsujimoto M; Kotani S; Okunaga T; Kubo T; Takada H; Kubo T; Shiba T; Kusumoto S; Takahashi T; Goto Y
Vaccine; 1989 Feb; 7(1):39-48. PubMed ID: 2718605
[TBL] [Abstract][Full Text] [Related]
13. Synthetic immunomodulators and synthetic vaccines.
Leclerc C; Vogel FR
Crit Rev Ther Drug Carrier Syst; 1986; 2(4):353-406. PubMed ID: 3103928
[TBL] [Abstract][Full Text] [Related]
14. Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen.
Tamura M; Yoo YC; Yoshimatsu K; Yoshida R; Oka T; Ohkuma K; Arikawa J; Azuma I
Vaccine; 1995 Jan; 13(1):77-82. PubMed ID: 7762283
[TBL] [Abstract][Full Text] [Related]
15. Immunostimulant activities of a lipophilic muramyl dipeptide derivative and of desmuramyl peptidolipid analogs.
Parant MA; Audibert FM; Chedid LA; Level MR; Lefrancier PL; Choay JP; Lederer E
Infect Immun; 1980 Mar; 27(3):826-31. PubMed ID: 7380554
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant activity of some nonpyrogenic hydrophobic analogues of muramyl dipeptide in enhancing the primary humoral and cell mediated immune responses in guinea pig model.
Saxena RP; Puri A; Saxena KC; Shukla R; Haq W; Rizvi SY; Kundu B; Mathur KB
Indian J Exp Biol; 1991 Feb; 29(2):111-5. PubMed ID: 1869292
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of immune responses by a muramyl dipeptide analog, MDP-Lys(L18).
Akasaki M; Takashi T; Kita Y; Tsukada W
Agents Actions; 1987 Oct; 22(1-2):144-50. PubMed ID: 3318323
[TBL] [Abstract][Full Text] [Related]
18. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
19. Biological studies of lipophilic MDP-derivatives incorporated in liposomes.
Jolivet M; Sache E; Audibert F
Immunol Commun; 1981; 10(6):511-22. PubMed ID: 7319546
[TBL] [Abstract][Full Text] [Related]
20. In vivo and in vitro stimulation of nonspecific immunity by the beta-D-p-aminophenyl glycoside of N-acetylmuramyl-L-alanyl-D-isoglutamine and an oligomer prepared by cross-linking with glutaraldehyde.
Parant M; Damais C; Audibert F; Parant F; Chedid L; Sache E; Lefrancier P; Choay J; Lederer E
J Infect Dis; 1978 Sep; 138(3):378-86. PubMed ID: 100563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]